TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35601869

Group type: EXPERIMENTAL
Intervention: Rehabilitation training guidance based on automatic extraction algorithm
Number of subjects: 81

Group type: COMPARATOR
Intervention: Routine nursing (Control)
Number of subjects: 81
Study: 34158553

Group type: EXPERIMENTAL
Intervention: Self-guided Internet-based intervention for gambling problems (8 weeks)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Wait-list control group with access to treatment-as-usual
Number of subjects: 150
Study: 32932401

Group type: EXPERIMENTAL
Intervention: E2/P4 (17β-estradiol/progesterone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32740133

Group type: EXPERIMENTAL
Intervention: Preadmission procedure-specific consent document
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no preadmission procedure-specific consent document)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Preadmission procedure-specific consent document (subgroup analysis)
Number of subjects: 70
Study: 33905794

Group type: EXPERIMENTAL
Intervention: Bacterial infections (BIs)
Number of subjects: 201

Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 201
Study: 35950904

Group type: EXPERIMENTAL
Intervention: Transcranial photobiomodulation (t‐PBM) with near‐infrared (NIR) light (830 nm; continuous wave; 35.8 cm2 treatment area; 54.8 mW/cm2 irradiance; 65.8 J/cm2 fluence; 20 min/session; 2 W total power; 2.3 kJ total energy per session), delivered to the prefrontal cortex, bilaterally, twice a week for 6 weeks.
Number of subjects: 49

Group type: COMPARATOR
Intervention: Sham treatment (control group).
Number of subjects: 49
Study: 35372974

Group type: EXPERIMENTAL
Intervention: Educational video (video first condition)
Number of subjects: 1905

Group type: COMPARATOR
Intervention: Control group (video last condition)
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Educational video effect on nondonors
Number of subjects: 1905

Group type: EXPERIMENTAL
Intervention: Racial differences in organ donation intent
Number of subjects: 1905
Study: 32462198

Group type: EXPERIMENTAL
Intervention: Vision-related quality of life (VRQoL) assessment using the NEI VFQ-25 questionnaire
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Longitudinal assessment after 1.08 (0.78) years with a median of 2 (2) follow-up visits
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Association of VRQoL with visual functional and structural biomarkers
Number of subjects: 87
Study: 35817673

Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg the night before surgery, 3 mg in the morning, and 3 mg at bedtime until the third day after CABG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (1 placebo tablet instead of melatonin, administered similarly to the M group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 100
Study: 34366819

Group type: EXPERIMENTAL
Intervention: Robot-Assisted Therapy (RT)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Constraint-Induced Movement Therapy (CIMT)
Number of subjects: 51
Study: 36371154

Group type: EXPERIMENTAL
Intervention: iCBT+TAU
Number of subjects: 266

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 266
Study: 35984478

Group type: EXPERIMENTAL
Intervention: CGM-guided insulin adjustment
Number of subjects: 185

Group type: COMPARATOR
Intervention: POC-guided insulin adjustment
Number of subjects: 185
Study: 33771956

Group type: EXPERIMENTAL
Intervention: Full-time wear schedule
Number of subjects: 25

Group type: COMPARATOR
Intervention: Gradually increasing wear schedule
Number of subjects: 25
Study: 32950830

Group type: EXPERIMENTAL
Intervention: Montelukast combined with intranasal mometasone furoate (Group I)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intranasal mometasone furoate alone (Group II)
Number of subjects: 100
Study: 36148627

Group type: EXPERIMENTAL
Intervention: Milky lotions containing mevalonolactone (MVL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo milky lotions
Number of subjects: 0
Study: 35901370

Group type: EXPERIMENTAL
Intervention: Immediate training in LGBTQ-affirmative cognitive behavioral therapy (CBT) for 11 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 121
Study: 33600233

Group type: EXPERIMENTAL
Intervention: SPN-812 (Viloxazine Extended-Release)
Number of subjects: 0
Study: 33118872

Group type: EXPERIMENTAL
Intervention: Inoculation with 5 × 5 mm mycelial discs of Epicoccum sorghinum
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group treated with sterile PDA disks
Number of subjects: 10
Study: 35283098

Group type: EXPERIMENTAL
Intervention: Endoscopic vein harvest (EVH)
Number of subjects: 957

Group type: COMPARATOR
Intervention: Open vein harvest (OVH)
Number of subjects: 957
Study: 33318125

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 14
Study: 32720085

Group type: EXPERIMENTAL
Intervention: Wider range of losses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Wider range of gains
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher stakes in previous session
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Currency units ('pennies')
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Currency units ('pounds')
Number of subjects: 0
Study: 34175127

Group type: EXPERIMENTAL
Intervention: GMZ2/alum
Number of subjects: 1849

Group type: COMPARATOR
Intervention: Rabies vaccine
Number of subjects: 1849
Study: 35060943

Group type: EXPERIMENTAL
Intervention: Low FODMAP Diet (LFD)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Psyllium (6 g/d)
Number of subjects: 43
Study: 32827122

Group type: EXPERIMENTAL
Intervention: NHF 20 L/min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: NHF 50 L/min
Number of subjects: 12

Group type: COMPARATOR
Intervention: Positive Airway Pressure (PAP) therapy
Number of subjects: 12

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 12
Study: 33401975

Group type: EXPERIMENTAL
Intervention: Flywheel resistance training (weekly session for 10 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 32362155

Group type: EXPERIMENTAL
Intervention: Blended psychosocial support program (1 face-to-face contact, 6 online guided modules, 1 telephone contact)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 148
Study: 35183160

Group type: EXPERIMENTAL
Intervention: Flipped Classroom through Near Peer Education (FC through NPE)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Conventional education method (Control)
Number of subjects: 82
Study: 34118065

Group type: EXPERIMENTAL
Intervention: Intensified support by clinical pharmacologists/pharmacists for patients and treatment team
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Advanced medication reviews performed by clinical pharmacologists/pharmacists
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: New oral anticancer drug regimen
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Drug-drug or drug-food interactions
Number of subjects: 202
Study: 32349070

Group type: COMPARATOR
Intervention: Preoperative angiotensin system inhibitors
Number of subjects: 5864

Group type: COMPARATOR
Intervention: Postoperative angiotensin system inhibitors
Number of subjects: 5864

Group type: COMPARATOR
Intervention: Control (no angiotensin system inhibitors preoperatively)
Number of subjects: 5864

Group type: COMPARATOR
Intervention: Control (no angiotensin system inhibitors postoperatively)
Number of subjects: 5864
Study: 34407780

Group type: EXPERIMENTAL
Intervention: FIT screening with a positive test result
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Self-reported diet, lifestyle, and demographic data collection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fecal samples for gut microbiome analyses collected before and 2 and 12 months after colonoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linking CRCbiome data to national registries
Number of subjects: 0
Study: 36145099

Group type: EXPERIMENTAL
Intervention: Lean red meat (Pirenaica breed)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Lean white meat (chicken)
Number of subjects: 47
Study: 33065080

Group type: EXPERIMENTAL
Intervention: 1-month dual antiplatelet therapy (DAPT; ticagrelor and aspirin) followed by 23-month ticagrelor monotherapy
Number of subjects: 1651

Group type: COMPARATOR
Intervention: 12-month DAPT followed by 12-month aspirin monotherapy
Number of subjects: 1651
Study: 34528897

Group type: EXPERIMENTAL
Intervention: iGAM app intervention group (photographed gums weekly for 8 weeks)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Wait-list control group (photographed gums at recruitment and 8 weeks later)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups received the same message regarding oral hygiene after photo submission
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Recent dental visits
Number of subjects: 160
Study: 33120766

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine-remifentanil
Number of subjects: 69

Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Postoperative pain and patient satisfaction
Number of subjects: 69
Study: 35241319

Group type: EXPERIMENTAL
Intervention: Bariatric surgery (73% Roux‐en‐Y) prior to THA
Number of subjects: 71

Group type: COMPARATOR
Intervention: Contemporary bariatric techniques
Number of subjects: 71
Study: 33725858

Group type: EXPERIMENTAL
Intervention: Domperidone
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Sulpiride
Number of subjects: 306

Group type: COMPARATOR
Intervention: Control (regular routine of PEG)
Number of subjects: 306
Study: 35835726

Group type: EXPERIMENTAL
Intervention: iCT‐SAD
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: CT‐SAD
Number of subjects: 102

Group type: COMPARATOR
Intervention: WAIT
Number of subjects: 102
Study: 32875456

Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Usual Activities (Control)
Number of subjects: 24
Study: 32945775

Group type: EXPERIMENTAL
Intervention: mHealth-based diabetes self-management education through a mobile app and regular individualized feedback from health care professionals
Number of subjects: 66

Group type: COMPARATOR
Intervention: Previous diabetes management strategies
Number of subjects: 66
Study: 34628506

Group type: EXPERIMENTAL
Intervention: Health consequences about the cardiovascular system
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Health consequences about the mouth
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Health consequences about other digestive issues
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Health consequences about the respiratory system
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Health consequences about early death
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Awareness of the health consequence
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Length of the warning message (number of characters)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Cancer health consequences
Number of subjects: 777

Group type: COMPARATOR
Intervention: Plain language health consequences
Number of subjects: 777
Study: 34671129

Group type: EXPERIMENTAL
Intervention: Mendelian randomisation (MR) and genetic correlation (GC) methods
Number of subjects: 95
Study: 32555573

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily with aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 0
Study: 36438208

Group type: EXPERIMENTAL
Intervention: Optimized cancer screening (sending invitation letters to non-adherent women and sending GPs a list of their non-adherent patients)
Number of subjects: 94393

Group type: EXPERIMENTAL
Intervention: Standard cancer screening (sending invitation letters to non-adherent women)
Number of subjects: 94393

Group type: COMPARATOR
Intervention: Usual care (no letters sent to women or GPs)
Number of subjects: 94393
Study: 34037666

Group type: EXPERIMENTAL
Intervention: WIV04 vaccine (5 µg/dose; n=13,459)
Number of subjects: 40382

Group type: EXPERIMENTAL
Intervention: HB02 vaccine (4 µg/dose; n=13,465)
Number of subjects: 40382

Group type: COMPARATOR
Intervention: Alum-only control (n=13,458)
Number of subjects: 40382

Group type: EXPERIMENTAL
Intervention: All groups (WIV04, HB02, alum-only)
Number of subjects: 40382
Study: 32533785

Group type: EXPERIMENTAL
Intervention: Apatinib combined with four cycles of docetaxel or pemetrexed
Number of subjects: 37

Group type: COMPARATOR
Intervention: Four cycles of docetaxel or pemetrexed
Number of subjects: 37
Study: 35241476

Group type: EXPERIMENTAL
Intervention: Invasive mechanical ventilation
Number of subjects: 0
Study: 32795597

Group type: EXPERIMENTAL
Intervention: Initial advanced airway management with laryngeal tube or endotracheal intubation
Number of subjects: 3002
Study: 35253623

Group type: EXPERIMENTAL
Intervention: Moderate aerobic training on the treadmill, three times a week, for 12 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study: 34001682

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (rich in fresh vegetables and fruits, low in saturated and unsaturated fats and carbohydrates, low in food additives, sugar, fast foods and processed foods) and vitamin D supplementation, curcumin, and flax seeds.
Number of subjects: 73
Study: 32933221

Group type: EXPERIMENTAL
Intervention: Upper lip horizontal line (ULHL) presence in females
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Patients presenting ULHL characteristics
Number of subjects: 643

Group type: EXPERIMENTAL
Intervention: Skeletal pattern analysis in patients with ULHL
Number of subjects: 643
Study: 35950763

Group type: EXPERIMENTAL
Intervention: Dialogic learning
Number of subjects: 4

Group type: COMPARATOR
Intervention: Discussion-based learning
Number of subjects: 4
Study: 33491839

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lindeman bur
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Diamond-tipped piezo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Piezosurgery
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laser surgery
Number of subjects: 60
Study: 32321345

Group type: EXPERIMENTAL
Intervention: Intravenous cyclophosphamide (CTX)
Number of subjects: 94

Group type: COMPARATOR
Intervention: SLE without DAH
Number of subjects: 94
Study: 36183689

Group type: EXPERIMENTAL
Intervention: Adaptation test
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Unilateral stance test
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sensor organization test
Number of subjects: 37
Study: 32309974

Group type: EXPERIMENTAL
Intervention: Housing Outreach Program‐Collaboration (HOP‐C) plus treatment as usual
Number of subjects: 65

Group type: COMPARATOR
Intervention: Transitional case management plus treatment as usual
Number of subjects: 65
Study: 34776188

Group type: EXPERIMENTAL
Intervention: Swedish massage on quadriceps for 20-30 min per session (12 sessions)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Regular treatment (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Swedish massage
Number of subjects: 30
Study: 33020088

Group type: EXPERIMENTAL
Intervention: AGT-Reha enhanced home-based exercise training
Number of subjects: 84

Group type: COMPARATOR
Intervention: Medical exercise therapy (MET)
Number of subjects: 84
Study: 35106605

Group type: EXPERIMENTAL
Intervention: Adaptation group (received eight unexpected, overground, nonparetic-side gait-slips followed by two paretic-side slips)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Adaptation group (novel paretic-side slips)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Adaptation group (compared to control group on the 2nd paretic slip)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (received two paretic-side slips)
Number of subjects: 49
Study: 32401683

Group type: EXPERIMENTAL
Intervention: Blocked practice schedule
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Random practice schedule
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Tasks A, B, and C (both blocked and random practice)
Number of subjects: 41
Study: 32736576

Group type: EXPERIMENTAL
Intervention: Vaginal palpation with verbal instructions about PFM function and body awareness techniques
Number of subjects: 172

Group type: COMPARATOR
Intervention: Control group (similar protocol without vaginal palpation)
Number of subjects: 172
Study: 36055230

Group type: EXPERIMENTAL
Intervention: ctDNA-guided risk stratification
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard adjuvant chemotherapy
Number of subjects: 0
Study: 34929392

Group type: COMPARATOR
Intervention: Control diet (23 g/d fiber)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Minimally-fermented sugarcane bagasse (33 g/d fiber)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Fiber combination (sugarcane bagasse with resistant starch, ∼45 g/d fiber)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Fiber-supplemented diets vs control diet
Number of subjects: 26
Study: 33802283

Group type: EXPERIMENTAL
Intervention: Creatine (CRE) supplementation at 0.3 g·kg−1·d−1 for seven days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA, maltodextrin) for seven days
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Creatine (CRE) supplementation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 32216456

Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 609

Group type: EXPERIMENTAL
Intervention: Erenumab (combined dose group)
Number of subjects: 609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 609
Study: 35623844

Group type: EXPERIMENTAL
Intervention: HIGH mycoprotein (nucleotide-rich)
Number of subjects: 20

Group type: COMPARATOR
Intervention: LOW mycoprotein (nucleotide-depleted)
Number of subjects: 20
Study: 34019724

Group type: EXPERIMENTAL
Intervention: E-learning cultural competence intervention
Number of subjects: 113
Study: 32479328

Group type: EXPERIMENTAL
Intervention: IPT-Dyad
Number of subjects: 42

Group type: COMPARATOR
Intervention: ETAU
Number of subjects: 42
Study: 36203818

Group type: EXPERIMENTAL
Intervention: Continuous Erector Spinae Plane Block (CESPB)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intravenous Patient-Controlled Opioid Analgesia (PCIA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CESPB
Number of subjects: 120
Study: 34002265

Group type: EXPERIMENTAL
Intervention: Hexvix® TURB with immediate ICT only (n=67, 40 mg Mitomycin)
Number of subjects: 129

Group type: COMPARATOR
Intervention: white-light TURB with immediate ICT followed by maintenance ICT (n=62, 20 mg Mitomycin weekly for 6 weeks, then 20 mg/month for 6 months)
Number of subjects: 129
Study: 36269714

Group type: EXPERIMENTAL
Intervention: 3HR (three months of daily isoniazid plus rifampicin)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 3HP (three months of once-weekly isoniazid plus rifapentine)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: 4R (four months of daily rifampicin)
Number of subjects: 225
Study: 34800298

Group type: COMPARATOR
Intervention: IPSRT (Interpersonal and Social Rhythm Therapy)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: IPSRT-CR (IPSRT with Cognitive Remediation)
Number of subjects: 68

Group type: COMPARATOR
Intervention: IPSRT
Number of subjects: 68

Group type: COMPARATOR
Intervention: IPSRT vs IPSRT-CR
Number of subjects: 68
Study: 32152482

Group type: EXPERIMENTAL
Intervention: Blood pressure less than 130/80 mmHg
Number of subjects: 447

Group type: EXPERIMENTAL
Intervention: baPWV above 1731 cm/s
Number of subjects: 447
Study: 35762913

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) at 60% of maximal inspiratory pressure (MIP) for 8 weeks
Number of subjects: 26

Group type: COMPARATOR
Intervention: Sham IMT at 15% of maximal inspiratory pressure (MIP) for 8 weeks
Number of subjects: 26
Study: 32248506

Group type: EXPERIMENTAL
Intervention: Skull thickness measurements at various sites (midline anterior, midline posterior, right lateral, left lateral, antero-lateral, postero-lateral)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Skull thickness measurements at the end of growth
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Recommendations for pin tip size based on age
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Variability in skull thickness in children aged <4 years
Number of subjects: 270
Study: 32586344

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Doxycycline (Control)
Number of subjects: 200
Study: 37256485

Group type: EXPERIMENTAL
Intervention: Active ophthalmic drops (Latilactobacillus sakei)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo ophthalmic drops
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Active oral capsules (Latilactobacillus sakei)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo oral capsules
Number of subjects: 40
Study: 33660668

Group type: EXPERIMENTAL
Intervention: Nonclinic-based adolescent behavioral weight control treatment delivered by YMCA coaches
Number of subjects: 66
Study: 32508129

Group type: EXPERIMENTAL
Intervention: Two-month home exercise program with one-hour sessions delivered by a physiotherapist
Number of subjects: 60

Group type: COMPARATOR
Intervention: Minimal education about shoulder condition and instructions to continue activities as normal
Number of subjects: 60
Study: 35940835

Group type: EXPERIMENTAL
Intervention: Home-based multimodal prehabilitation (exercise and nutrition) for >3 weeks
Number of subjects: 750

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 750
Study: 34420228

Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 29

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 29
Study: 32774567

Group type: EXPERIMENTAL
Intervention: Infiltration series with techniques such as sphenopalatine ganglion (SPG) block and ganglionic local opioid analgesia (GLOA)
Number of subjects: 83
Study: 36297022

Group type: EXPERIMENTAL
Intervention: Astragalosides supplementation (4 mg per day for 7 days)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Astragalosides supplementation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 11
Study: 32170553

Group type: EXPERIMENTAL
Intervention: Surgical Aortic Valve Replacement (SAVR)
Number of subjects: 220